Home » Newsletters » BioWorld

BioWorld

July 21, 2003

View Archived Issues

Vicuron Grosses $83.1M Through Public Offering Of Common Stock

Vicuron Pharmaceuticals Inc. priced a public offering of stock that raised $83.1 million in gross proceeds. (BioWorld Today) Read More

Medarex Raises $100M Via Notes Sale, Adds To Financing Flurry

Human Chromosome 7 Sequenced, Reveals New Data On Elfin Facies Of Childhood Congenital Syndrome

Isotechnika Completes $15M Funding With U.S. Investors

Bionaut Advancing Programs Following Series A Financing

Other News To Note

Appointments And Advancements